Weekly Dose: Kalydeco, the drug that treats the cause of cystic fibrosis, not just symptoms
- Written by Odette Erskine, Respiratory and Sleep Medicine Physician; Clinical Lecturer, University of Sydney

Kalydeco (ivacaftor) is a drug used to treat cystic fibrosis, a disorder that affects many organs, particularly the lungs. Cystic fibrosis is Australia’s most commonly inherited disorder.
The drug has...